Can CA-125/CEA ratio be used for the differential diagnosis between ovarian and nonovarian cancers? A research letter
Int J Surg
.
2024 Nov 1;110(11):7397-7400.
doi: 10.1097/JS9.0000000000002015.
Authors
Jeferson R Zanon
1
,
Elisa B Simioni
2
,
Flávia F Barbin
3
,
Priscila G Pedrão
4
,
Carlos E M C Andrade
5
,
Diocésio A P de Andrade
6
,
João P Bilibio
7
,
José H T G Fregnani
8
9
,
Ricardo Dos Reis
10
11
12
Affiliations
1
Department of Nephrology and Palliative Care at Jales Cancer Hospital (a Barretos Cancer Hospital Unit - Pio XII Foundation), Jales.
2
Department of Gynecologic Oncology at Jaú Cancer Hospital (Amaral Carvalho Foundation), Jaú.
3
Department of Pathology at Barretos Cancer Hospital (Pio XII Foundation).
4
Molecular Oncology Research Center, Barretos Cancer Hospital (Pio XII Foundation).
5
Department of Gynecologic Oncology at Barretos Cancer Hospital (Pio XII Foundation), Barretos.
6
Clinical Oncology Department, InORP Oncoclínicas Group, Ribeirão Preto, São Paulo.
7
Brusque Medical School (UNIFEBE), Brusque, Santa Catarina.
8
A.C. Camargo Cancer Center, São Paulo.
9
Graduate Program at Barretos Cancer Hospital (Pio XII Foundation), Barretos, São Paulo.
10
Department of Gynecologic Oncology.
11
Educational and Research Institute.
12
Graduate Program at Barretos Cancer Hospital (Pio XII Foundation), Barretos, São Paulo, Brazil.
PMID:
39166953
PMCID:
PMC11573086
DOI:
10.1097/JS9.0000000000002015
No abstract available